Lars Jørgen Østergaard

Cohort Profile: The Bissau HIV Cohort-a cohort of HIV-1, HIV-2 and co-infected patients

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Standard

Cohort Profile : The Bissau HIV Cohort-a cohort of HIV-1, HIV-2 and co-infected patients. / Jespersen, Sanne; Hønge, Bo Langhoff; Oliveira, Inés; Medina, Candida; da Silva Té, David; Correira, Faustino Gomes; Erikstrup, Christian; Laursen, Alex Lund; Ostergaard, Lars; Wejse, Christian; for the Bissau HIV Cohort study group.

In: International Journal of Epidemiology, 22.10.2014.

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Harvard

Jespersen, S, Hønge, BL, Oliveira, I, Medina, C, da Silva Té, D, Correira, FG, Erikstrup, C, Laursen, AL, Ostergaard, L, Wejse, C & for the Bissau HIV Cohort study group 2014, 'Cohort Profile: The Bissau HIV Cohort-a cohort of HIV-1, HIV-2 and co-infected patients', International Journal of Epidemiology. https://doi.org/10.1093/ije/dyu201

APA

Jespersen, S., Hønge, B. L., Oliveira, I., Medina, C., da Silva Té, D., Correira, F. G., Erikstrup, C., Laursen, A. L., Ostergaard, L., Wejse, C., & for the Bissau HIV Cohort study group (2014). Cohort Profile: The Bissau HIV Cohort-a cohort of HIV-1, HIV-2 and co-infected patients. International Journal of Epidemiology. https://doi.org/10.1093/ije/dyu201

CBE

Jespersen S, Hønge BL, Oliveira I, Medina C, da Silva Té D, Correira FG, Erikstrup C, Laursen AL, Ostergaard L, Wejse C, for the Bissau HIV Cohort study group. 2014. Cohort Profile: The Bissau HIV Cohort-a cohort of HIV-1, HIV-2 and co-infected patients. International Journal of Epidemiology. https://doi.org/10.1093/ije/dyu201

MLA

Vancouver

Jespersen S, Hønge BL, Oliveira I, Medina C, da Silva Té D, Correira FG et al. Cohort Profile: The Bissau HIV Cohort-a cohort of HIV-1, HIV-2 and co-infected patients. International Journal of Epidemiology. 2014 Oct 22. https://doi.org/10.1093/ije/dyu201

Author

Jespersen, Sanne ; Hønge, Bo Langhoff ; Oliveira, Inés ; Medina, Candida ; da Silva Té, David ; Correira, Faustino Gomes ; Erikstrup, Christian ; Laursen, Alex Lund ; Ostergaard, Lars ; Wejse, Christian ; for the Bissau HIV Cohort study group. / Cohort Profile : The Bissau HIV Cohort-a cohort of HIV-1, HIV-2 and co-infected patients. In: International Journal of Epidemiology. 2014.

Bibtex

@article{29febfc15e1e4f8d820047c4be5e2ae2,
title = "Cohort Profile: The Bissau HIV Cohort-a cohort of HIV-1, HIV-2 and co-infected patients",
abstract = "The West African country Guinea-Bissau is home to the world's highest prevalence of HIV-2, and its HIV-1 prevalence is rising. Other chronic viral infections like human T-lymphotropic virus type 1 (HTLV-1) and hepatitis B virus are common as well. The Bissau HIV Cohort was started in 2007 to gain new insights into the overall effect of introducing antiretroviral treatment in a treatment-na{\"i}ve population with concomitant infection with three retroviruses (HIV-1, HIV-2 and HTLV-1) and tuberculosis. The cohort includes patients from the HIV clinic at Hospital Nacional Sim{\~a}o Mendes, the main hospital in Bissau, the capital of the country. From July 2007 to June 2013, 3762 HIV-infected patients (69% HIV-1, 18% HIV-2, 11% HIV-1/2 and 2% HIV type unknown) were included in the world's largest single-centre HIV-2 cohort. Demographic and clinical data are collected at baseline and every 6 months, together with CD4 cell count and routine biochemistry analyses. Plasma and cells are stored in a biobank in Denmark. The Bissau HIV Cohort is administered by the Bissau HIV Cohort study group. Potential collaborators are invited to contact the chair of the cohort study group, Christian Wejse, e-mail: [wejse@dadlnet.dk].",
author = "Sanne Jespersen and H{\o}nge, {Bo Langhoff} and In{\'e}s Oliveira and Candida Medina and {da Silva T{\'e}}, David and Correira, {Faustino Gomes} and Christian Erikstrup and Laursen, {Alex Lund} and Lars Ostergaard and Christian Wejse and {for the Bissau HIV Cohort study group}",
note = "{\textcopyright} The Author 2014; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association.",
year = "2014",
month = oct,
day = "22",
doi = "10.1093/ije/dyu201",
language = "English",
journal = "International Journal of Epidemiology",
issn = "0300-5771",
publisher = "Oxford University Press",

}

RIS

TY - JOUR

T1 - Cohort Profile

T2 - The Bissau HIV Cohort-a cohort of HIV-1, HIV-2 and co-infected patients

AU - Jespersen, Sanne

AU - Hønge, Bo Langhoff

AU - Oliveira, Inés

AU - Medina, Candida

AU - da Silva Té, David

AU - Correira, Faustino Gomes

AU - Erikstrup, Christian

AU - Laursen, Alex Lund

AU - Ostergaard, Lars

AU - Wejse, Christian

AU - for the Bissau HIV Cohort study group

N1 - © The Author 2014; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association.

PY - 2014/10/22

Y1 - 2014/10/22

N2 - The West African country Guinea-Bissau is home to the world's highest prevalence of HIV-2, and its HIV-1 prevalence is rising. Other chronic viral infections like human T-lymphotropic virus type 1 (HTLV-1) and hepatitis B virus are common as well. The Bissau HIV Cohort was started in 2007 to gain new insights into the overall effect of introducing antiretroviral treatment in a treatment-naïve population with concomitant infection with three retroviruses (HIV-1, HIV-2 and HTLV-1) and tuberculosis. The cohort includes patients from the HIV clinic at Hospital Nacional Simão Mendes, the main hospital in Bissau, the capital of the country. From July 2007 to June 2013, 3762 HIV-infected patients (69% HIV-1, 18% HIV-2, 11% HIV-1/2 and 2% HIV type unknown) were included in the world's largest single-centre HIV-2 cohort. Demographic and clinical data are collected at baseline and every 6 months, together with CD4 cell count and routine biochemistry analyses. Plasma and cells are stored in a biobank in Denmark. The Bissau HIV Cohort is administered by the Bissau HIV Cohort study group. Potential collaborators are invited to contact the chair of the cohort study group, Christian Wejse, e-mail: [wejse@dadlnet.dk].

AB - The West African country Guinea-Bissau is home to the world's highest prevalence of HIV-2, and its HIV-1 prevalence is rising. Other chronic viral infections like human T-lymphotropic virus type 1 (HTLV-1) and hepatitis B virus are common as well. The Bissau HIV Cohort was started in 2007 to gain new insights into the overall effect of introducing antiretroviral treatment in a treatment-naïve population with concomitant infection with three retroviruses (HIV-1, HIV-2 and HTLV-1) and tuberculosis. The cohort includes patients from the HIV clinic at Hospital Nacional Simão Mendes, the main hospital in Bissau, the capital of the country. From July 2007 to June 2013, 3762 HIV-infected patients (69% HIV-1, 18% HIV-2, 11% HIV-1/2 and 2% HIV type unknown) were included in the world's largest single-centre HIV-2 cohort. Demographic and clinical data are collected at baseline and every 6 months, together with CD4 cell count and routine biochemistry analyses. Plasma and cells are stored in a biobank in Denmark. The Bissau HIV Cohort is administered by the Bissau HIV Cohort study group. Potential collaborators are invited to contact the chair of the cohort study group, Christian Wejse, e-mail: [wejse@dadlnet.dk].

U2 - 10.1093/ije/dyu201

DO - 10.1093/ije/dyu201

M3 - Journal article

C2 - 25342251

JO - International Journal of Epidemiology

JF - International Journal of Epidemiology

SN - 0300-5771

ER -